Search Reports


Healthcare » Pharmaceuticals »

OTC Drugs Market Size, share Outlook and Opportunities 2019- 2025

  • ID:OGAHM1907564
  • Published: June-2019
  • Pages:140
  • OG Analysis
1 of 3

Global OTC Drugs Market Outlook and Growth Opportunities to 2025: By Type (Analgesics, Cold & Cough Remedies, Digestives & Intestinal Remedies, Skin Treatment, and Vitamins & Minerals), By Distribution Channel (Online and Offline) and By Region

Global OTC Drugs Market is poised to report 7.76% growth in 2019 as compared to 2018.Increase in allergic reactions, frequent aching, and other diet deficiency problems due to changing eating habits and busy lifestyles is boosting the adoption of OTC drugs across the world wide. The global OTC Drugs Market is estimated to register a market value of USD 117.31 Billion in 2019.

The increasing healthcare awareness across all age groups is resulting into high demand for OTC drugs. Changing lifestyles is pushing the adoption of OTC drugs such as skin products, weight loss drugs, and others are anticipated to fuel the market growth.

Growing interference of regulatory bodies and associations for controlling and monitoring of sale of OTC drugs for determining which drugs to be sold or not is a key factor restraining the market demand. In addition, maintaining strict standards for pharmaceuticals to be sold as OTC drugs is hindering the market growth.

Furthermore, increasing competition among the existing players, complications and severity in taking wrong medications owing to incorrect self-diagnosis, and lack of awareness among the rural population in emerging economies are the factors restraining the growth of OTC drug market.

Market demand by type

The report analyses the global OTC drugs market based on type as analgesics, cold & cough remedies, digestives & intestinal remedies, skin treatment, and vitamins & minerals.

Globally, vitamins and minerals category dominated the OTC drugs market due to their wide consumption in emerged countries including Germany, United States, and other countries. Consumption of various vitamins and minerals is expected to continue at rapid rate in commercial countries, which further enhances the market demand.

Analgesics is one of the popular OTC medication groups across the world and holds a significant market share. Conversely, factors such as drug abuse and uncontrolled use leading to increased deaths, which restrains the product demand. Furthermore, insufficient regulatory guidelines about the drugs are anticipated to hamper the market growth.

The demand for cold &cough remedies is increasing in all almost all countries and will experience the conventional seasonal trend over the forecast period 2019-2025. Continous increasing demand and number of products in the cold &cough category are anticipated to augment the industry growth in upcoming years. Growing number of individuals affected with cold and cough every year multiple times is driving the segment demand in the market.

Market demand by distribution channel

The report analyses the global OTC drugs market based on distribution channel as online channel and offline channel.

Online sales of OTC drugs are increasing at a rapid pace, but not similarly for all OTC categories of drugs. The Internet is increasingly becoming a popular distribution channel driven by convenience, as online shopping permits consumers to quickly compare costs of products and provide direct and complete shipping.

Increasing awareness through media including TV, print circular, social media home pages are propelling the OTC drugs industry growth.

North America OTC drugs market occupies major share:

The report analyses the global OTC drugs market for countries across North America, Europe, Asia Pacific, South & Central America and Middle East & Africa.

Increasing number of chemists and pharma dispensaries, in which the drugs are readily available at low costs is boosting the North America OTC drugs market. USA is the biggest market for OTC drugs in North America, which accounts for more than 80% of the market. Although the market share is high in this region, it is projected to witness saturation owing to the dominance of generic medicine prescription.

OTC drugs regional market is highly concentrated in handful major economies of the world. Together, U.S., China and Japan accounted for nearly 50% of the industry share in 2018. During the forecast period, U.S and Japan market will experience modest growth, owing to market saturation in some product category. However, technologically better products should boost business growth.

APAC region is expected to witness significant increase in terms of demand for Over-the-Counter (OTC) drugs and China market is holding a significant market share with over 15% of global over-the-counter drugs market share.

Prominent key players in global OTC drug market:

Johnson and Johnson, Novartis AG, Bayer AG, Pfizer, Sanofi, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Perrigo Company PLC, Takeda Pharmaceutical Company Ltd and Cipla, Inc.

Scope:

Long term perspective on the OTC Drugs industry: 2018 (base year), 2019- 2025 (forecast period)

OTC Drugs Market- Forecasts by Segments- Type and Distribution Channel by geography.

1. The research report classifies the global healthy snack market into 5 types including analgesics, cold & cough remedies, digestives & intestinal remedies, skin treatment, and vitamins & minerals.

2. The research report classifies the global healthy snack market in to 2 distribution channels include online and offline.

3. The report analyses the global healthy snack across countries in 5 regions including Asia-Pacific, Europe, North America, South & Central America and Middle East &Africa.

OTC Drugs Market- Strategic Analysis Review

1. Key strategies opted by leading players

2. Short to Long Term Industry Trends

3. Porter’s Five Forces Analysis

4. Supply side and Demand Side Drivers and Challenges

OTC Drugs Market- Growth Opportunities

1. Potential New Business Opportunities

2. Key Areas of Focus in forecast period

OTC Drugs Market- Competitive Scenario

1. 10 companies are analysed in the report including Johnson and Johnson, Novartis AG, Bayer AG, Pfizer, Sanofi, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Perrigo Company PLC, Takeda Pharmaceutical Company Ltd and Cipla, Inc.

2. Company Peer-to-Peer Comparison

3. Company Profile and SWOT Analysis

4. Financial Analysis

1 of 3

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Introduction to Global OTC Drugs Market
2.1 Global OTC Drugs Market Snapshot, 2018
2.2 OTC Drugs Industry Overview
2.3 Research Perspective

3. Global OTC Drugs Market- Strategic Analysis
3.1 Short Term and Long Term Industry Trends Affecting Global OTC Drugs Markets
3.2 Leading OTC Drugs Types Targeted by Global Manufacturers
3.3 Key Consumption Patterns of OTC Drugs
3.4 Potential Markets Vital for business Expansion
3.5 Five Forces Analysis
3.6 Drivers and Restraints

4. Global OTC Drugs Market Outlook and Growth Opportunities by Type
4.1Analgesics Market Outlook, 2019- 2025
4.2 Cold & Cough Remedies Market Outlook, 2019- 2025
4.3 Digestives & Intestinal Remedies Market Outlook, 2019- 2025
4.4 Skin Treatment Market Outlook, 2019- 2025
4.5Vitamins & Minerals Market Outlook, 2019- 2025

5. Global OTC Drugs Market Outlook and Growth Opportunities by Distribution Channel
5.1 OTC Drugs Demand from Online Distribution Channel, Market Outlook, 2019- 2025
5.2 OTC Drugs Demand from Offline Distribution Channel, Market Outlook, 2019- 2025

6. Asia Pacific OTC Drugs Market Outlook and Growth Opportunities
6.1 Key Findings, 2018
6.2 Asia Pacific OTC Drugs Market Outlook by Type, 2019- 2025
6.3 Asia Pacific OTC Drugs Market Outlook by Distribution Channel, 2019- 2025
6.4 Asia Pacific OTC Drugs Market Outlook by Country, 2019- 2025

7. Europe OTC Drugs Market Outlook and Growth Opportunities
7.1 Key Findings, 2018
7.2 Europe OTC Drugs Market Outlook by Type, 2019- 2025
7.3 Europe OTC Drugs Market Outlook by Distribution Channel, 2019- 2025
7.4 Europe OTC Drugs Market Outlook by Country, 2019- 2025

8. North America OTC Drugs Market Outlook and Growth Opportunities
8.1 Key Findings, 2018
8.2 North America OTC Drugs Market Outlook by Type, 2019- 2025
8.3 North America OTC Drugs Market Outlook by Distribution Channel, 2019- 2025
8.4 North America OTC Drugs Market Outlook by Country, 2019- 2025

9. South & Central America OTC Drugs Market Outlook and Growth Opportunities
9.1 Key Findings, 2018
9.2 South & Central America OTC Drugs Market Outlook by Type, 2019- 2025
9.3 South & Central America OTC Drugs Market Outlook by Distribution Channel, 2019- 2025
9.4 South & Central America OTC Drugs Market Outlook by Country, 2019- 2025

10. Middle East & Africa OTC Drugs Market Outlook and Growth Opportunities
10.1 Key Findings, 2018
10.2 Middle East & Africa OTC Drugs Market Outlook by Type, 2019- 2025
10.3 Middle East & Africa OTC Drugs Market Outlook by Distribution Channel, 2019- 2025
10.4 Middle East & Africa OTC Drugs Market Outlook by Country, 2019- 2025

11. Competitive Landscape
11.1 Leading Players (Company Profile, SWOT Analysis, OTC Drugs, Financial Analysis)
11.1.1 Johnson and Johnson
11.1.2 Novartis AG
11.1.3 Bayer AG
11.1.4Pfizer
11.1.5 Sanofi
11.1.6GlaxoSmithKline PLC
11.1.7Reckitt Benckiser Group PLC
11.1.8Perrigo Company PLC
11.1.9Takeda Pharmaceutical Company Ltd
11.1.10 Cipla, Inc.
11.2 Company Benchmarking
11.3 Financial Analysis

12. Recent News and Deals Landscape
12.1 Mergers and Acquisitions
12.2 New Product Launches
12.3 Asset Transactions
12.3 Financial Announcements

13. Appendix
13.1 OGAnalysis Expertise
13.2 Sources and Research Methodology
13.3 Contact Information



1 of 3

Type Delivery Format Details
Hard Copy A printed copy of the report will be shipped to you.
CD-ROM The report will be shipped to you in CD ROM format.
SINGLE USER Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows one specific user access to the product.
SITE LICENSE Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows all users within a given geographical location of your organization access to the product.
ENTERPRISEWIDE Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows all employees within your organization in different geographic locations access to the product.
1 - 5 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to five users have access to the product.
1 – 10 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to ten users have access to the product.
1 – 15 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to fifteen users have access to the product.
1 - 5 USERS Online Access (For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to five users have access to the product.
1 - 10 USERS Online Access(For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to ten users have access to the product.
1 - 15 USERS Online Access(For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to fifteen users have access to the product.
1 - 5 USERS Electronic (Excel) The Excel spreadsheet will be emailed to you. The license allows up to five users have access to the product.

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-10 user licence, allowing up to ten users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.